CymaBay Therapeutics, Inc.

ROYAL BANK OF CANADA

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

94,260

Value ($000)

2,226

Weight

0.0%

2020 Q1 - 2023 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,226	0.0%	94,260	12/31/2023
2023 Q3	11/14/2023	1,065	0.0%	71,449	9/30/2023
2023 Q2	8/14/2023	67	0.0%	6,088	6/30/2023
2023 Q1	5/15/2023	0	0.0%	26	3/31/2023
2022 Q4	2/14/2023	66	0.0%	10,579	12/31/2022
2022 Q3	11/14/2022	27	0.0%	7,581	9/30/2022
2022 Q2	8/15/2022	4	0.0%	1,250	6/30/2022
2022 Q1	5/16/2022	16	0.0%	5,229	3/31/2022
2021 Q4	2/14/2022	46	0.0%	13,711	12/31/2021
2021 Q3	11/15/2021	31	0.0%	8,606	9/30/2021
2021 Q2	8/16/2021	27	0.0%	6,150	6/30/2021
2021 Q1	7/20/2021	33	0.0%	7,278	3/31/2021
2020 Q4	2/16/2021	9	0.0%	1,580	12/31/2020
2020 Q3	11/16/2020	9	0.0%	1,271	9/30/2020
2020 Q2	8/14/2020	8	0.0%	2,313	6/30/2020
2020 Q1	6/16/2020	20	0.0%	13,972	3/31/2020